C4 Therapeutics (CCCC) Market Capitalization (2020 - 2026)
Powered by 
Analysis
C4 Therapeutics (CCCC) Market Capitalization (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | C4 Therapeutics | 492.73 Mn | 239.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 573.97 Mn |
| Mar 31, 2026 | 273.62 Mn |
| Dec 31, 2025 | 185.11 Mn |
| Sep 30, 2025 | 164.67 Mn |
| Jun 30, 2025 | 101.54 Mn |
| Mar 31, 2025 | 113.58 Mn |
| Dec 31, 2024 | 254.25 Mn |
| Sep 30, 2024 | 402.21 Mn |
| Jun 30, 2024 | 317.93 Mn |
| Mar 31, 2024 | 561.92 Mn |
| Dec 31, 2023 | 280.47 Mn |
| Sep 30, 2023 | 91.62 Mn |
| Jun 30, 2023 | 134.93 Mn |
| Mar 31, 2023 | 154.02 Mn |
| Dec 31, 2022 | 288.90 Mn |
| Sep 30, 2022 | 429.30 Mn |
| Jun 30, 2022 | 368.54 Mn |
| Mar 31, 2022 | 1.18 Bn |
| Dec 31, 2021 | 1.57 Bn |
| Sep 30, 2021 | 2.17 Bn |